Prescription details
View BPC-157 care- Compound
- BPC-157
- Route
- Telehealth
- Prescriber
- Every request gets a clinical assessment. A U.S.-licensed clinician makes the prescribing decision.
- Availability
- For U.S. patients only. Treatment options depend on state rules and the medication, and some requests are declined.
Compounded BPC-157 has no FDA approval.
Cell movement & repair
Inside a moving cell: Agility Peptide
Actin held in reserve. Blood vessels growing into an injury. Collagen being rebuilt. Their coordination is my fascination here.
Actin in reserve
A cell has a surprisingly useful way of staying ready to move: it holds some of its building material back. In a 2004 structural study, a gelsolin-domain–thymosin beta-4 hybrid capped both ends of an individual actin unit, preventing it from joining a filament. The experiment resolved a molecular arrangement, rather than measuring anyone’s recovery.
Actin helps form the cell’s internal skeleton. Thymosin beta-4 binds its free units in a 1:1 complex, maintaining a reserve that helps regulate that skeleton’s assembly. The wider research on cell migration connects this regulation with wound closure and new blood-vessel growth.
I love the apparent contradiction: a protein associated with movement also holds things still. Agility, down here, involves control over assembly. That seems a far more interesting subject than another promise to speed everything up.
Vessels and matrix
The other peptides lead into different parts of this moving, rebuilding tissue. In chick membranes, rats and cultured human vascular cells, BPC-157 increased vessel growth through VEGFR2 signaling. The human cells were in a laboratory; the blood-flow recovery came from a rat model of impaired circulation. Interrupting the pathway, and losing the effect, is the persuasive move for me. There is something specific to investigate there.
GHK-Cu brings copper and matrix biology into the picture. Matrix is the material around cells, including collagen and elastin. A review of skin-regeneration studies describes both making new material and regulating its breakdown. Tissue remodeling requires room for both activities.
KLOW puts GHK-Cu, BPC-157, TB-500 and the anti-inflammatory tripeptide KPV together. The attraction is easy to understand. Their coordination as a blend remains an untested proposition; the component research cannot supply a combined result.
A larger dose, a missing benefit
The awkward result deserves space too. In a rat stroke experiment with full-length thymosin beta-4, 2 and 12 mg/kg improved neurological function; 18 mg/kg gave no significant benefit. These are amounts administered to rats in that experiment, with no human equivalent established here.
For me, the escalating-stimulation story fails at that turn in the curve. This study gives that doubt a concrete footing, although it settles neither a mechanism for the lost benefit nor a treatment for people. It also tested the full protein, while TB-500 is a short fragment. The sports-medicine review follows the evidence problem; the compound entry looks closely at the molecules.
Agil peptides and unfamiliar names
Agil peptides, ABP-7 peptide, adaptive peptides, peptidefacility: names can become slippery before the biology even begins. The compounds examined here have specific identities—BPC-157, the TB-500 fragment, copper-bound GHK and the KLOW mixture.
I can’t attach their findings to an unfamiliar name without a matching chemical identity. The comparison sets out the sequences and the forms tested; the questions page deals with the recurring confusions about growth hormone, timing and the blend.
BPC-157
A vessel-growth experiment with a useful interruption: block the receptor’s internalization, and the effect stops.
Examine the vessel response →TB-500
Actin in reserve, a seven-amino-acid fragment and the much larger protein behind most of the experiments.
Meet the two molecules →GHK-Cu
Copper binding, collagen remodeling and the surprisingly practical difficulties of getting across skin.
Look at the skin studies →KLOW
Four proposed contributions to repair, brought together before their combined behavior has been measured.
Consider the combination →